Clinical and radiological outcomes 5 years after matrix-induced autologous chondrocyte implantation in patients with symptomatic, traumatic chondral defects
- PMID: 22922521
- DOI: 10.1177/0363546512457008
Clinical and radiological outcomes 5 years after matrix-induced autologous chondrocyte implantation in patients with symptomatic, traumatic chondral defects
Abstract
Background: To date, few studies have been published reporting the 5-year follow-up of clinical and radiological outcomes for chondral defects treated with matrix-induced autologous chondrocyte implantation (MACI).
Hypothesis: A significant improvement in clinical and radiological outcomes after treatment of symptomatic, traumatic chondral defects of the knee with the MACI implant will be maintained up to 5 years after surgery.
Study design: Case series; Level of evidence, 4.
Methods: A prospective evaluation of the MACI procedure was performed in 21 patients with chondral defects of the knee. After the MACI procedure, patients were clinically assessed with the Knee injury and Osteoarthritis Outcome Score (KOOS), the Tegner-Lysholm score, the International Knee Documentation Committee (IKDC) Subjective Knee Form, and the modified Cincinnati score at years 1, 2, and 5. The quality of repair tissue was assessed by magnetic resonance imaging using the magnetic resonance observation of cartilage repair tissue (MOCART) score at months 3 and 6 and years 1, 2, and 5.
Results: Significant improvements (P < .05) were observed for all 5 KOOS subcategories at year 1 and were maintained through year 5 in 90.5% of patients (19/21). Treatment failure occurred in only 9.5% of patients (2/21). Significant improvements (P < .05) from baseline to year 5 were also observed for the IKDC score (30.1 to 74.3), the modified Cincinnati score (38.1 to 79.6), and the Tegner-Lysholm activity score (1.8 to 4.3). Similarly, the MOCART score significantly improved (P < .001) from baseline to year 5 (52.9 to 75.8). After 5 years, complete filling (83%) and integration (82%) of the graft were seen in the majority of patients. Signs of subchondral bone edema were still present in 47% of patients at 5 years. No product-specific adverse events were reported over the 5-year follow-up period.
Conclusion: Patients treated with a MACI implant demonstrated significant clinical improvement and good quality repair tissue 5 years after surgery. The MACI procedure was shown to be a safe and effective treatment for symptomatic, traumatic chondral knee defects in this study.
Similar articles
-
A randomized trial comparing accelerated and traditional approaches to postoperative weightbearing rehabilitation after matrix-induced autologous chondrocyte implantation: findings at 5 years.Am J Sports Med. 2012 Jul;40(7):1527-37. doi: 10.1177/0363546512445167. Epub 2012 Apr 26. Am J Sports Med. 2012. PMID: 22539536 Clinical Trial.
-
Repair of focal cartilage defects with scaffold-assisted autologous chondrocyte grafts: clinical and biomechanical results 48 months after transplantation.Am J Sports Med. 2011 Aug;39(8):1697-705. doi: 10.1177/0363546511403279. Epub 2011 May 3. Am J Sports Med. 2011. PMID: 21540360
-
[Treatment of deep cartilage defects of the knee with autologous chondrocyte transplantation on a hyaluronic Acid ester scaffolds (Hyalograft C)].Acta Chir Orthop Traumatol Cech. 2006 Aug;73(4):251-63. Acta Chir Orthop Traumatol Cech. 2006. PMID: 17026884 Czech.
-
Treatment of full-thickness chondral defects with autologous chondrocyte implantation.Orthop Clin North Am. 2005 Oct;36(4):433-46. doi: 10.1016/j.ocl.2005.06.005. Orthop Clin North Am. 2005. PMID: 16164949 Review.
-
Microfracture Versus Autologous Chondrocyte Implantation for Articular Cartilage Lesions in the Knee: A Systematic Review of 5-Year Outcomes.Am J Sports Med. 2018 Mar;46(4):995-999. doi: 10.1177/0363546517701912. Epub 2017 Apr 19. Am J Sports Med. 2018. PMID: 28423287
Cited by
-
Magnetic resonance imaging of stem cell apoptosis in arthritic joints with a caspase activatable contrast agent.ACS Nano. 2015 Feb 24;9(2):1150-60. doi: 10.1021/nn504494c. Epub 2015 Jan 26. ACS Nano. 2015. PMID: 25597243 Free PMC article.
-
Four cases report: Treatment of knee joint cartilage defects using autologous chondrocyte patch implantation.Front Surg. 2022 Nov 8;9:1015091. doi: 10.3389/fsurg.2022.1015091. eCollection 2022. Front Surg. 2022. PMID: 36425890 Free PMC article.
-
Cartilage regeneration using arthroscopic flushing fluid-derived mesenchymal stem cells encapsulated in a one-step rapid cross-linked hydrogel.Acta Biomater. 2018 Oct 1;79:202-215. doi: 10.1016/j.actbio.2018.08.029. Epub 2018 Aug 28. Acta Biomater. 2018. PMID: 30165202 Free PMC article.
-
Use of cell-free collagen type I matrix implants for the treatment of small cartilage defects in the knee: clinical and magnetic resonance imaging evaluation.Knee Surg Sports Traumatol Arthrosc. 2014 Jun;22(6):1270-6. doi: 10.1007/s00167-013-2747-x. Epub 2013 Nov 7. Knee Surg Sports Traumatol Arthrosc. 2014. PMID: 24196573
-
Treatment for cartilage injuries of the knee with a new treatment algorithm.World J Orthop. 2014 Nov 18;5(5):677-84. doi: 10.5312/wjo.v5.i5.677. eCollection 2014 Nov 18. World J Orthop. 2014. PMID: 25405097 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical